🦠 Recombinant Flu Vaccines Could Prevent Thousands of Hospitalizations: What You Need to Know
By Dr. Sk Sabir Rahaman, MBBS , MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD As flu season approaches, new research highlights how switching from traditional egg‑based flu vaccines to recombinant influenza vaccines (RIVs) might prevent tens of thousands of hospital stays in the United States. 🏥 What the Study Found A modeling analysis published on January 2, 2025 in JAMA Network Open explored how replacing standard inactivated influenza vaccines with RIVs across 10 flu seasons (2012–2023) might have impacted influenza-related hospitalizations Nature +6 JAMA Network +6 Medscape +6 Medscape . Key findings include: Among adults aged 50–64 , nearly 87,654 flu-related hospitalizations could have been avoided (95% CI: 74,518–101,482). Among adults aged 18–49 with chronic conditions , switching to RIVs could have prevented approximately 14,436 hospitalizations (95% CI: 10,100–19,963) Medscape . ⚠️ Why Adults 50–64 and Chronic Illness Gro...